Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360100 · ClinicalTrials.gov registry record · Phase 3
Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT00360100 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 120 participants.
The verdict
NCT00360100, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
Assess tolerability of different dosing formulations (adult versus pediatric).
Interventions
- DRUG Zmax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2006-08 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00360100
The ClinicalTrials.gov registry entry for NCT00360100 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zmax is the first listed.
NCT00360100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00360100 about?
NCT00360100 is a clinical study titled "Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media". Assess tolerability of different dosing formulations (adult versus pediatric).
What is the current status of trial NCT00360100?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2006-08. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00360100?
The interventions under investigation include: Zmax (DRUG).
Who is sponsoring clinical trial NCT00360100?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.